PL2000530T3 - Kompozycja szczepów z rodzaju Lactobacillus i zastosowanie kompozycji szczepów z rodzaju Lactobacillus - Google Patents

Kompozycja szczepów z rodzaju Lactobacillus i zastosowanie kompozycji szczepów z rodzaju Lactobacillus

Info

Publication number
PL2000530T3
PL2000530T3 PL08460016T PL08460016T PL2000530T3 PL 2000530 T3 PL2000530 T3 PL 2000530T3 PL 08460016 T PL08460016 T PL 08460016T PL 08460016 T PL08460016 T PL 08460016T PL 2000530 T3 PL2000530 T3 PL 2000530T3
Authority
PL
Poland
Prior art keywords
composition
lactobacillus strains
application
lactobacillus
anus
Prior art date
Application number
PL08460016T
Other languages
English (en)
Inventor
Piotr B Heczko
Magdalena Strus
Grzegorz Stefański
Katarzyna Dechnik
Original Assignee
Inst Biotechnologii Surowic I Szczepionek Biomed S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biotechnologii Surowic I Szczepionek Biomed S A filed Critical Inst Biotechnologii Surowic I Szczepionek Biomed S A
Publication of PL2000530T3 publication Critical patent/PL2000530T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL08460016T 2007-06-04 2008-05-21 Kompozycja szczepów z rodzaju Lactobacillus i zastosowanie kompozycji szczepów z rodzaju Lactobacillus PL2000530T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL382579A PL210465B1 (pl) 2007-06-04 2007-06-04 Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
EP08460016A EP2000530B1 (en) 2007-06-04 2008-05-21 Composition of lactobacillus strains and the application of the composition of lactobacillus strains

Publications (1)

Publication Number Publication Date
PL2000530T3 true PL2000530T3 (pl) 2010-10-29

Family

ID=39691310

Family Applications (2)

Application Number Title Priority Date Filing Date
PL382579A PL210465B1 (pl) 2007-06-04 2007-06-04 Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
PL08460016T PL2000530T3 (pl) 2007-06-04 2008-05-21 Kompozycja szczepów z rodzaju Lactobacillus i zastosowanie kompozycji szczepów z rodzaju Lactobacillus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL382579A PL210465B1 (pl) 2007-06-04 2007-06-04 Zastosowanie kompozycji szczepów z rodzaju Lactobacillus

Country Status (9)

Country Link
US (1) US8632766B2 (pl)
EP (1) EP2000530B1 (pl)
AT (1) ATE474911T1 (pl)
DE (1) DE602008001829D1 (pl)
ES (1) ES2347205T3 (pl)
PL (2) PL210465B1 (pl)
PT (1) PT2000530E (pl)
RU (1) RU2465320C2 (pl)
UA (1) UA96744C2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1396972B1 (it) * 2009-02-03 2012-12-20 Sitar S R L Prodotto medicinale e/o alimentare e/o integratore alimentare e/o probiotico e/o prodotto omeopatico con lisati e/o tindalizzati di batteri fisiologici, lisati e/o tindalizzati di miceti fisiologici, lisati e/o tindalizzati di spore microbiche fisiologiche
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
EE05750B1 (et) * 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
CN104140937B (zh) * 2014-05-24 2017-01-25 东北农业大学 植物乳杆菌klds1001及其在抑制口腔变异链球菌中的用途
EP3064072A1 (en) * 2015-02-11 2016-09-07 AB-Biotics S.A. Probiotic lactobacillus strains for use in treating urinary tract infections
RU2709464C2 (ru) 2015-09-29 2019-12-18 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
CA3018035A1 (en) * 2016-03-24 2017-09-28 Probiotical S.P.A. Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections
ITUA20162013A1 (it) * 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
AU2017327504B2 (en) * 2016-09-16 2024-08-22 International N&H Denmark Aps Bacteria
US12029748B2 (en) 2017-02-28 2024-07-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN108004187B (zh) * 2018-01-11 2020-03-10 广东龙创基药业有限公司 一种格氏乳杆菌及其用于制备阴道抑菌药物的应用
KR102488609B1 (ko) * 2020-09-24 2023-01-12 국립낙동강생물자원관 장내 유해세균 억제 기능을 가진 락토바실러스 파라부크네리 nsmj16 (kacc81129bp) 및 락토바실러스 브레비스 nsmj23(kacc81130bp)
CN120114491B (zh) * 2025-05-13 2025-07-11 微康益生菌(苏州)股份有限公司 一种改善女性生殖道衰老的后生元菌剂及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
SE9501056D0 (sv) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
JP4163276B2 (ja) 1998-02-05 2008-10-08 独立行政法人理化学研究所 機能性組成物
ATE207755T1 (de) 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
PL190233B1 (pl) 1998-06-04 2005-11-30 Inst Biotechnologii Przemyslu Bakteryjny biopreparat dla zwierząt i sposób wytwarzania bakteryjnego biopreparatu dla zwierząt
US6479051B1 (en) 1998-12-11 2002-11-12 Urex Biotex, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
ATE419331T1 (de) * 2000-08-25 2009-01-15 Wakamoto Pharma Co Ltd L. salivarius-stamm enthaltende probiotische produkte
US20040028665A1 (en) * 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
DE60322570D1 (de) 2002-06-28 2008-09-11 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
US7122370B2 (en) * 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
US20060062773A1 (en) * 2004-09-21 2006-03-23 The Procter & Gamble Company Compositions for maintaining and restoring normal gastrointestinal flora
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
PL209447B1 (pl) * 2005-03-09 2011-09-30 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Nowe szczepy z rodzaju Lactobacillus i kompozycja składająca się z nowych szczepów z rodzaju Lactobacillus
AU2006297896B2 (en) 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases

Also Published As

Publication number Publication date
UA96744C2 (ru) 2011-12-12
ATE474911T1 (de) 2010-08-15
RU2008122368A (ru) 2009-12-10
PL210465B1 (pl) 2012-01-31
ES2347205T3 (es) 2010-10-26
RU2465320C2 (ru) 2012-10-27
US20080299099A1 (en) 2008-12-04
EP2000530B1 (en) 2010-07-21
EP2000530A1 (en) 2008-12-10
DE602008001829D1 (de) 2010-09-02
PL382579A1 (pl) 2008-12-08
US8632766B2 (en) 2014-01-21
PT2000530E (pt) 2010-09-30

Similar Documents

Publication Publication Date Title
PT2000530E (pt) Composição de estirpes de lactobacillus e aplicação da composição das estirpes de lactobacillus
Slover et al. Lactobacillus: a review
WO2003033681A3 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
EP4257194A3 (en) Use of microbial communities for human and animal health
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
DK1624762T3 (da) Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab
ATE323503T1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
IL191795A (en) Use of Bacillus 6pb for the preparation of drugs for the prevention or treatment of gastrointestinal and related disorders @ the @ immune system
FR3063646B1 (fr) Bacteries specifiques pour leur utilisation comme medicament en particulier pour lutter contre le surpoids, l'obesite, les maladies cardiometaboliques et les maladies inflammatoires de l'intestin
GB2465051A (en) Probiotic bifidobacterium strains
RU2013126599A (ru) Нереплицирующиеся пробиотические микроорганизмы, защищающие против инфекций верхних дыхательных путей
ATE533499T1 (de) Bacillus smithii-stamm tbmi12 mscl p737 und verwendung von endosporen davon als probiotisches mittel oder nahrungszusatz
PT1773361E (pt) Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal
RU2010142003A (ru) Синбиотическая смесь
ZA202110476B (en) Composition with antibacterial and re-epithelializing action including probiotics
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
SA519400920B1 (ar) استخدام المعززات الحيوية في علاج و/أو الوقاية من التهاب الجلد التأتبي
MX2025010695A (es) Consorcios microbianos
WO2003045405A3 (fr) Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
ATE541468T1 (de) Mikrobielle futterergänzungsmittel und verwendungen davon in verfahren zur verringerung und/oder verhinderung von azidose in polygastrischen pflanzenfressern
AU2024290329A1 (en) Bifidobacterium animalis subsp lactis strain cect 8145 and lta thereof health uses
EP1582186B8 (en) Condom coated with lactobacillus compositions
Puniya et al. Probiotic and functional attributes of Lactobacillus spp isolated from human faeces
Thayalana et al. In VitroAntimicrobial Activity and Aggregation Abilities of Probiotic Lactobacillus caseiand Lactobacillus salivariusAgainst Oral Pathogens
DE602004032530D1 (de) Rdauungsfunktion